🇺🇸 FDA
Patent

US 10544126

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

granted A61KA61K31/454A61K31/4545

Quick answer

US patent 10544126 (Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases) held by Takeda Pharmaceutical Company Limited expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/454, A61K31/4545, A61K45/06, A61P